Evidence map›Paper›PMID 32218116›Full record

ArticleNutrients2020

Effects of Rambutan Peel (

Yongliang Zhuang, Xiaodong Sun, Bingtong Liu, Hu Hou, Yun Sun

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Role of vitamins in the development and treatment of osteoporosis (Review).International journal of molecular medicine · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Inhibitory Effect ofMedicina (Kaunas, Lithuania) · 2022
    Article
  7. A Comparison of the Antiosteoporotic Effects of Cornelian Cherry (Oxidative medicine and cellular longevity · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Anti-osteoporotic Effect ofIranian journal of pharmaceutical research : IJPR
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yongliang ZhuangInstitute of Agriculture and Food, Kunming University of Science and Technology, No. 727 South Jingming Road, Kunming 650500, China.
Xiaodong SunInstitute of Agriculture and Food, Kunming University of Science and Technology, No. 727 South Jingming Road, Kunming 650500, China.
Bingtong LiuInstitute of Agriculture and Food, Kunming University of Science and Technology, No. 727 South Jingming Road, Kunming 650500, China.
Hu HouFood Science and Technology, Ocean University of China, No 5, Yushan Road, Qingdao, Shandong 266005, China.
Yun SunInstitute of Agriculture and Food, Kunming University of Science and Technology, No. 727 South Jingming Road, Kunming 650500, China.
Kunming University of Science and Technology · CNOcean University of China · CN

Funding

National Natural Science Foundation of China 31360381
6 · The paper itself

Abstract

Previous studies have shown that rambutan peel phenolic (RPP) extract has excellent biological activities due to its abundant phenolic content and profile. In this study, the potential anti-osteoporosis (OP) effects of RPP were evaluated by suppressing receptor activator nuclear factor-kappa B ligand (RANKL)-induced differentiation of RAW264.7 cells into osteoclasts and amelioratingretinoic acid-induced OP in rats. Our results showed that RPP efficiently decreased the formation of tartrate-resistant acid phosphatase (TRAP)-positive cells and reduced total TRAP activity in RAW264.7 cells under RANKL stimulation. RPP treatment significantlyameliorated retinoid acid-induced calcium loss in rats (

Indexed as

AnimalsBiomarkersBiopsyBody WeightBone DensityCell DifferentiationCell SurvivalDisease Models, AnimalImmunohistochemistryMiceOsteoclastsOsteogenesisOsteoporosisPhenolsPlant ExtractsRANK LigandBiomarkersPhenolsPlant ExtractsRANK LigandTretinoinbone qualityhistological analysisosteoporosisrambutanpeel phenolicRAW264.7 cellsreceptor activator nuclear factor-kappa B ligand(RANKL)

Identifiers

PMID32218116
PMCPMC7230481
OpenAlexW3014003298

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.